High
spatial resolution imaging analysis is urgently needed to
explore the biodistribution, transfer and clearance profiles, and
biological impact of nanoparticles in the body, which will be helpful
to clarify the efficacy of nanomedicine in clinical applications.
Herein, by combination with multiscale synchrotron-based imaging techniques,
including X-ray fluorescence (XRF) spectrometry, Fourier transform
infrared (FTIR) spectroscopy, and micro X-ray phase contrast computed
tomography (micro-XPCT), we visually displayed the transfer patterns
and site-specific distribution of PEGylated gold nanoparticles (PEG-GNPs)
in the suborgans of the liver, spleen, and kidney after an intravenous
injection in mice. A combination of XRF and FTIR imaging analysis
showed that the PEG bands presented similar distribution patterns
with Au in the intraorgans, suggesting the stability of PEGylation
on GNPs. We show that the PEG-GNPs presented heterogeneous distribution
in the hepatic lobules with a large amount around the portal vein
zone and then a gradient decrease in the sinusoidal region and the
CV zone; in the spleen, it gradually accumulated in the splenic red
pulp over time; and in the kidney, it quickly transported via the
bloodstream to the renal pyramids and renal pelvis, and parts of PEG-GNPs
finally accumulated in the renal medulla and renal cortex. Multidimensional
micro-XPCT images further show that the PEG-GNP transfer in the liver
induced hepatic blood vessel dilatation while they transferred in
the liver, providing evidence of GNP transport across the blood vessel
endothelial barrier.